FDA orphan drug designation: treatment of adenoid cystic carcinoma
All entries for: Rgenta Therapeutics Inc.
September 3, 2025
Rgenta Therapeutics Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of adenoid cystic carcinoma
